Home » Topics » HIV/AIDS, BioWorld Science

HIV/AIDS, BioWorld Science
RSS

Expanded access program for HIV protease inhibitor

Sep. 20, 1996

AIDS treatment to enter clinical trials in Japan

Sep. 20, 1996

Anti-HIV compounds from Janssen

Sep. 20, 1996

Promising preliminary results with DMP-266

Sep. 20, 1996

Reticulose study in AIDS patients

Sep. 13, 1996

New HIV protease inhibitors from Searle

Sep. 13, 1996

CMV protease structure solved

Sep. 13, 1996

Higher doses recommended for Protovir study

Sep. 6, 1996

Anti-HIV activity reported for Onconase

Sep. 6, 1996

Women with AIDS-related wasting syndrome to receive testosterone skin patch

Sep. 6, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...